Yates Clayton Clopton
Yates Clayton Clopton, DIR, reported a transaction classified as grant at Genvor Inc involving 200000.000000 shares for an estimated $100000.00. Reported holdings after the transaction were 600000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Apr 15, 2026
- Filing date
- Nov 03, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingGNVR price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001213900-26-115335 Common Stock
- Transaction date
- Apr 15, 2026 Filed Nov 03, 2026, 05:53 PM · 202d delay
- Shares
- 200,000 sh $0.50 per share
- Estimated value
- $100k Computed from shares × price
- Holdings after
- 600,000 sh Indirect · ACT Holdings, LLC
Filing signal explanations
Badges describe filing facts only — not predictions.
-28 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.
How this score is calculated
- grant_or_award-22 points
transaction_code = A
Grant or award transactions are scheduled compensation, not discretionary. - delayed_filing-6 points
reporting_delay_days = 202
Filing delay exceeds the configured threshold.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
Shares issued upon Dr. Yates' conversion of $100,000 in outstanding payables owed by the Company to Dr. Yates, pursuant to his scientific advisor agreement with the Company and the Company's restructu…
- F2
Dr. Yates has voting and dispositive power with respect to shares held in the name of ACT Holdings, LLC, and is therefore deemed to be beneficial owner of shares held in its name.
0 other transactions
0 recent txs